Evidence-based decision making in healthcare in Central Eastern Europe

Expert Rev Pharmacoecon Outcomes Res. 2014 Oct;14(5):611-5. doi: 10.1586/14737167.2014.946014. Epub 2014 Aug 4.

Authors

Alessandra Ferrario¹, Dragana Baltezarević, Tanja Novakovic, Mark Parker, Janko Samardzic

Affiliation

¹ London School of Economics and Political Science, LSE Health, Houghton Street, London, UK.

PMID: 25090222
DOI: 10.1586/14737167.2014.946014

No abstract available

Publication types

Congress
Research Support, Non-U.S. Gov't

MeSH terms

Benchmarking
Cost-Benefit Analysis
Decision Support Techniques*
Drug Costs
Europe, Eastern
Evidence-Based Medicine / economics*
Health Care Costs*
Humans
Insurance, Health, Reimbursement / economics
Models, Economic*
Technology Assessment, Biomedical / economics